EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Growth and Adult Height Attainment in Danish Transgender Adolescents Treated With GnRH Analog and Sex Hormones

Pernille Badsberg Norup iD, Mette Ewers Haahr, Peter Christiansen, Lise Aksglaede, Line Cleemann, Trine Holm Johannsen iD, Anders Juul iD, Katharina M Main

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae263 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Pernille Badsberg Norup und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Body Height, Transgender Persons, Gonadotropin-Releasing Hormone, Testosterone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Sygeforsikring "danmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endogenous sex steroids influence the pubertal growth spurt and adult height. However, the impact of puberty suppression and sex steroids on growth in transgender adolescents is sparsely studied.

Aim

We investigated pubertal growth, serum IGF-I and IGF binding protein-3 (IGFBP-3), and adult height of transgender adolescents receiving hormone therapy.

Methods

Observational study of a national cohort (2016-2023) comprising 219 transgender adolescents <18 years of age. Treatment consisted of gonadotropin-releasing hormone agonist combined with estradiol or testosterone (adjusted to serum concentrations between 0 and +2 SDs corresponding to the gender identity).

Results

Adult height was within ±2 SD for sex assigned at birth. Most trans girls reached adult height within references of girls. For trans girls (bone age ≤15 years before treatment), a growth spurt was observed during estradiol therapy. IGF-I and height SD score (SDS) declined during oral estradiol administration (−0.13 SDS per month, P = .059, and −0.02 SDS, P = .001, respectively). We observed significantly lower adult height compared to target height for trans girls (−2.7 cm, P = .01) and significant differences between height SDS before treatment and at adult height (−0.35 SDS, P < .001). Half of the trans boys remained short (<−2 SD) compared to references for boys, and most completed growth spurt before initiation of treatment. IGFBP-3 declined following testosterone treatment. There was a significant difference between height SDS before treatment and at adult height (−0.17 SDS, P < .001). Discussion and Conclusion The minor reduction in adult height of trans girls after hormone treatment may be beneficial to some, whereas trans boys did not experience height gain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body HeightTransgender PersonsGonadotropin-Releasing HormoneTestosteroneEstradiolHumansAdolescentMaleFemaleDenmarkInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IPubertyTranssexualism

Stichwörter der Autor:innen

estradiolgender dysphoriagnRH analoggrowthtestosteronetransgender

Substanzen

Gonadotropin-Releasing HormoneTestosteroneEstradiolInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IIGF1 protein, humanIGFBP3 protein, human

Autor:innen und Institutionen

  • Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
  • International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.
  • Sexological Clinic, Mental Health Centre, Copenhagen University Hospital-Mental Health Services CPH, 2100 Copenhagen, Denmark.

ORCID-Profile: Pernille Badsberg Norup, Trine Holm Johannsen, Anders Juul

Förderung

  • Novo Nordisk Foundation
  • Sygeforsikring "danmark

Zitieren

APA

Norup, P. B., Haahr, M. E., Christiansen, P., Aksglaede, L., Cleemann, L., Johannsen, T. H., Juul, A., & Main, K. M. (2024). Growth and Adult Height Attainment in Danish Transgender Adolescents Treated With GnRH Analog and Sex Hormones. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae263

Vancouver

Norup PB, Haahr ME, Christiansen P, Aksglaede L, Cleemann L, Johannsen TH, et al. Growth and Adult Height Attainment in Danish Transgender Adolescents Treated With GnRH Analog and Sex Hormones. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae263

BibTeX
@article{Norup2024,
  author = {Norup, Pernille Badsberg and Haahr, Mette Ewers and Christiansen, Peter and Aksglaede, Lise and Cleemann, Line and Johannsen, Trine Holm and Juul, Anders and Main, Katharina M},
  title = {Growth and Adult Height Attainment in Danish Transgender Adolescents Treated With GnRH Analog and Sex Hormones},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae263}
}
Kostenlos starten →